PPAR-γ impairment alters peroxisome functionality in primary astrocyte cell cultures

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Di Cesare Mannelli, Lorenzo ^a   Zanardelli, Matteo ^a   Micheli, Laura ^a   Ghelardini, Carla ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; ACYL COENZYME A OXIDASE; CATALASE; GLUTATHIONE; GLUTATHIONE REDUCTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROSIGLITAZONE; 2-CHLORO-5-NITROBENZANILIDE; ANILIDE; ANTIOXIDANT; NERVE PROTEIN; OXIDOREDUCTASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ANIMAL CELL; ARTICLE; ASTROCYTE CULTURE; CELL FUNCTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DENATURATION; ENZYME INHIBITION; FLOW CYTOMETRY; INCUBATION TIME; INTRACELLULAR SIGNALING; NONHUMAN; PEROXISOME; PROTEIN EXPRESSION; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; ASTROCYTE; CELL CULTURE; DEGENERATIVE DISEASE; METABOLISM; PATHOLOGY; PRIMARY CELL CULTURE; SPRAGUE DAWLEY RAT;

ANILIDES; ANIMALS; ANTIOXIDANTS; ASTROCYTES; CELLS, CULTURED; NERVE TISSUE PROTEINS; NEURODEGENERATIVE DISEASES; OXIDOREDUCTASES; PEROXISOMES; PPAR ALPHA; PPAR GAMMA; PRIMARY CELL CULTURE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84897829700     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/546453     Document Type: Article

References (81)

1. Schrader M., Fahimi H. D., Peroxisomes and oxidative stress. Biochimica et Biophysica Acta 2006 1763 12 1755 1766 2-s2.0-33845292901 10.1016/j.bbamcr.2006.09.006 (Pubitemid 44880480)
2. Moldovan L., Moldovan N. I., Oxygen free radicals and redox biology of organelles. Histochemistry and Cell Biology 2004 122 4 395 412 2-s2.0-8644255769 10.1007/s00418-004-0676-y (Pubitemid 39506596)
3. Ježek P., Hlavatá L., Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. International Journal of Biochemistry and Cell Biology 2005 37 12 2478 2503 2-s2.0-25844520458 10.1016/j.biocel.2005.05.013 (Pubitemid 41400319)
4. Putnam C. D., Arvai A. S., Bourne Y., Tainer J. A., Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism. Journal of Molecular Biology 2000 296 1 295 309 2-s2.0-0034635333 10.1006/jmbi.1999.3458
5. Powers S. K., Jackson M. J., Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiological Reviews 2008 88 4 1243 1276 2-s2.0-55949118714 10.1152/physrev.00031.2007
6. De Duve C., Baudhuin P., Peroxisomes (microbodies and related particles). Physiological Reviews 1966 46 2 323 357 2-s2.0-0013897667
7. Elliott B. M., Dodd N. J. F., Elcombe C. R., Increased hydroxyl radical production in liver peroxisomal fractions from rats treated with peroxisome proliferators. Carcinogenesis 1986 7 5 795 799 2-s2.0-0022965484 (Pubitemid 17130641)
8. Zwacka R. M., Reuter A., Pfaff E., Moll J., Gorgas K., Karasawa M., Weiher H., The glomerulosclerosis gene Mpv17 encodes a peroxisomal protein producing reactive oxygen species. The EMBO Journal 1994 13 21 5129 5134 2-s2.0-0028117114 (Pubitemid 24341094)
9. Stolz D. B., Zamora R., Vodovotz Y., Loughran P. A., Billiar T. R., Kim Y.-M., Simmons R. L., Watkins S. C., Peroxisomal localization of inducible nitric oxide synthase in hepatocytes. Hepatology 2002 36 1 81 93 2-s2.0-0036288639 10.1053/jhep.2002.33716 (Pubitemid 34700765)
10. Wanders R. J. A., Waterham H. R., Biochemistry of mammalian peroxisomes revisited. Annual Review of Biochemistry 2006 75 295 332 2-s2.0-33746366462 10.1146/annurev.biochem.74.082803.133329 (Pubitemid 44118035)
11. Powers J. M., Moser H. W., Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions, and pathogenesis. Brain Pathology 1998 8 1 101 120 2-s2.0-0031963520 (Pubitemid 28055768)
12. Baes M., Aubourg P., Peroxisomes, myelination, and axonal integrity in the CNS. Neuroscientist 2009 15 4 367 379 2-s2.0-68949151976 10.1177/1073858409336297
13. Bottelbergs A., Verheijden S., Van Veldhoven P. P., Just W., Devos R., Baes M., Peroxisome deficiency but not the defect in ether lipid synthesis causes activation of the innate immune system and axonal loss in the central nervous system. Journal of Neuroinflammation 2012 61 2-s2.0-84858979826 10.1186/1742-2094-9-61
14. Trompier D., Vejux A., Zarrouk A., Gondcaille C., Geillon F., Nury T., Savary S., Lizard G., Brain peroxisomes. Biochimie 2013 10.1016/j.biochi.2013. 09.009
15. D'amico A., Bertini E., Metabolic neuropathies and myopathies. Handbook of Clinical Neurology 2013 113 1437 1455
16. Giordano C. R., Terlecky S. R., Peroxisomes, cell senescence, and rates of aging. Biochimica et Biophysica Acta 2012 1822 1358 1362 2-s2.0-84859779894 10.1016/j.bbadis.2012.03.013
17. Cimini A., Moreno S., D'Amelio M., Cristiano L., D'Angelo B., Falone S., Benedetti E., Carrara P., Fanelli F., Cecconi F., Amicarelli F., Cerù M. P., Early biochemical and morphological modifications in the brain of a transgenic mouse model of Alzheimer's disease: a role for peroxisomes. Journal of Alzheimer's Disease 2009 18 4 935 952 2-s2.0-74949133060 10.3233/JAD-2009- 1199
18. Wood P. L., Mankidy R., Ritchie S., Heath D., Wood J. A., Flax J., Goodenowe D. B., Circulating plasmalogen levels and Alzheimer disease assessment scale-cognitive scores in Alzheimer patients. Journal of Psychiatry and Neuroscience 2010 35 1 59 62 2-s2.0-75449092205 10.1503/jpn.090059
19. Igarashi M., Ma K., Gao F., Kim H.-W., Rapoport S. I., Rao J. S., Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. Journal of Alzheimer's Disease 2011 24 3 507 517 2-s2.0-79957828723 10.3233/JAD-2011-101608
20. Kou J., Kovacs G. G., Höftberger R., Kulik W., Brodde A., Forss-Petter S., Hönigschnabl S., Gleiss A., Brügger B., Wanders R., Just W., Budka H., Jungwirth S., Fischer P., Berger J., Peroxisomal alterations in Alzheimer's disease. Acta Neuropathologica 2011 122 3 271 283 2-s2.0-80054704470 10.1007/s00401-011-0836-9
21. Fransen M., Nordgren M., Wang B., Apanasets O., Role of peroxisomes in ROS/RNS-metabolism: implications for human disease. Biochimica et Biophysica Acta 2012 1822 1363 1373 2-s2.0-84855209862 10.1016/j.bbadis.2011.12.001
22. Shi R., Zhang Y., Shi Y., Shi S., Jiang L., Inhibition of peroxisomal beta-oxidation by thioridazine increases the amount of VLCFAs and Abeta generation in the rat brain. Neuroscience Letters 2012 528 6 10
23. Hunter R. L., Bing G., Agonism of peroxisome proliferator receptor-gamma may have therapeutic potential for neuroinflammation and Parkinson's disease. Current Neuropharmacology 2007 5 1 35 46 2-s2.0-33947709892 10.2174/ 157015907780077123 (Pubitemid 46488265)
24. Landreth G., Jiang Q., Mandrekar S., Heneka M., PPAR γ agonists as therapeutics for the treatment of Alzheimer's disease. Neurotherapeutics 2008 5 3 481 489 2-s2.0-46749115113 10.1016/j.nurt.2008.05.003 (Pubitemid 351952487)
25. Lee Y.-J., Han S. B., Nam S.-Y., Oh K.-W., Hong J. T., Inflammation and Alzheimer's disease. Archives of Pharmacal Research 2010 33 10 1539 1556 2-s2.0-78449234130 10.1007/s12272-010-1006-7
26. Lourenco M. V., Ledo J. H., Targeting Alzheimer's pathology through PPAR γ signaling: modulation of microglial function. The Journal of Neuroscience 2013 33 5083 5084
27. Swanson C. R., Joers V., Bondarenko V., Brunner K., Simmons H. A., Ziegler T. E., Kemnitz J. W., Johnson J. A., Emborg M. E., The PPAR- γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys. Journal of Neuroinflammation 2011 8, article 91 2-s2.0-79961103714 10.1186/1742-2094-8-91
28. Benedusi V., Martorana F., Brambilla L., Maggi A., Rossi D., The peroxisome proliferator-activated receptor γ (PPAR γ) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis. The Journal of Biological Chemistry 2012 287 43 35899 35911 10.1074/jbc.M112.366419
29. Napolitano M., Costa L., Palermo R., Giovenco A., Vacca A., Gulino A., Protective effect of pioglitazone, a PPAR γ ligand, in a 3 nitropropionic acid model of Huntington's disease. Brain Research Bulletin 2011 85 3-4 231 237 2-s2.0-79957858160 10.1016/j.brainresbull.2011.03.011
30. Heneka M. T., Landreth G. E., Hüll M., Drug Insight: effects mediated by peroxisome proliferator-activated receptor- γ in CNS disorders. Nature Clinical Practice Neurology 2007 3 9 496 504 2-s2.0-34548494847 10.1038/ncpneuro0586 (Pubitemid 47377609)
31. Issemann I., Green S., Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990 347 6294 645 650 2-s2.0-0025132245 10.1038/347645a0 (Pubitemid 20356241)
32. Girnun G. D., Domann F. E., Moore S. A., Robbins M. E. C., Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. Molecular Endocrinology 2002 16 12 2793 2801 2-s2.0-0036908619 10.1210/me.2002-0020 (Pubitemid 36020658)
33. Li C., Zhao R., Gao K., Wei Z., Yin M. Y., Lau L. T., Chui D., Yu A. C. H., Astrocytes: implications for neuroinflammatory pathogenesis of Alzheimer's disease. Current Alzheimer Research 2011 8 1 67 80 2-s2.0-79951707099 10.2174/156720511794604543
34. Kipp M., van der Valk P., Amor S., Pathology of multiple sclerosis. CNS & Neurological Disorders-Drug Targets 2012 11 506 517
35. Brambilla L., Martorana F., Rossi D., Astrocyte signaling and neurodegeneration: new insights into CNS disorders. Prion 2013 7 28 36
36. McCarthy K. D., De Vellis J., Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. Journal of Cell Biology 1980 85 3 890 902 2-s2.0-0019313317 (Pubitemid 10007455)
37. Ahmadian M., Suh J. M., Hah N., Liddle C., Atkins A. R., Downes M., Evans R. M., PPAR γ signaling and metabolism: the good, the bad and the future. Nature Medicine 2013 19 557 566
38. Jiang C., Ting A. T., Seed B., PPAR- γ agonists inhibit production of monocyte inflammatory cytokines. Nature 1998 391 6662 82 86 2-s2.0-0031888958 10.1038/34184 (Pubitemid 28079219)
39. Ricote M., Li A. C., Willson T. M., Kelly C. J., Glass C. K., The peroxisome proliferator-activated receptor- γ is a negative regulator of macrophage activation. Nature 1998 391 6662 79 82 2-s2.0-0031886864 10.1038/34178 (Pubitemid 28079218)
40. Chen Y.-C., Wu J.-S., Tsai H.-D., Huang C.-Y., Chen J.-J., Sun G. Y., Lin T.-N., Peroxisome proliferator-activated receptor gamma (PPAR- γ) and neurodegenerative disorders. Molecular Neurobiology 2012 46 114 124 2-s2.0-84858322522 10.1007/s12035-012-8259-8
41. Antonenkov V. D., Sormunen R. T., Hiltunen J. K., The behavior of peroxisomes in vitro: mammalian peroxisomes are osmotically sensitive particles. American Journal of Physiology 2004 287 6 C1623 C1635 2-s2.0-8644248303 10.1152/ajpcell.00142.2004 (Pubitemid 39507680)
42. Loughran P. A., Stolz D. B., Vodovotz Y., Watkins S. C., Simmons R. L., Billiar T. R., Monomeric inducible nitric oxide synthase localizes to peroxisomes in hepatocytes. Proceedings of the National Academy of Sciences of the United States of America 2005 102 39 13837 13842 2-s2.0-25444518977 10.1073/pnas.0503926102 (Pubitemid 41377665)
43. Brown G. C., Borutaite V., There is no evidence that mitochondria are the main source of reactive oxygen species in mammalian cells. Mitochondrion 2012 12 1 1 4 2-s2.0-84856556021 10.1016/j.mito.2011.02.001
44. Venkateshappa C., Harish G., Mahadevan A., Srinivas Bharath M. M., Shankar S. K., Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer's disease. Neurochemical Research 2012 37 1601 1614 2-s2.0-84858970841 10.1007/s11064-012-0755-8
45. Ghanizadeh A., Akhondzadeh S., Hormozi M., Makarem A., Abotorabi-Zarchi M., Firoozabadi A., Glutathione-related factors and oxidative stress in autism, a review. Current Medicinal Chemistry 2012 19 4000 4005
46. 2 release from intact peroxisomes. Biochemical Journal 2002 363 3 483 491 2-s2.0-0036566164 10.1042/0264-6021:3630483 (Pubitemid 34526368)
47. Cardaci S., Filomeni G., Rotilio G., Ciriolo M. R., p38MAPK/p53 signalling axis mediates neuronal apoptosis in response to tetrahydrobiopterin- induced oxidative stress and glucose uptake inhibition: implication for neurodegeneration. Biochemical Journal 2010 430 3 439 451 2-s2.0-77956659871 10.1042/BJ20100503
48. Iwashita S., Tsuchida M., Tsukuda M., Yamashita Y., Emi Y., Kida Y., Komori M., Kashiwayama Y., Imanaka T., Sakaguchi M., Multiple organelle-targeting signals in the N-terminal portion of peroxisomal membrane protein PMP70. Journal of Biochemistry 2010 147 4 581 590 2-s2.0-77950604267 10.1093/jb/mvp205
49. Kikuchi M., Hatano N., Yokota S., Shimozawa N., Imanaka T., Taniguchi H., Proteomic analysis of rat liver peroxisome. Presence of peroxisome-specific isozyme of Lon protease. Journal of Biological Chemistry 2004 279 1 421 428 2-s2.0-0345791524 10.1074/jbc.M305623200 (Pubitemid 38044842)
50. Morita M., Imanaka T., Peroxisomal ABC transporters: structure, function and role in disease. Biochimica et Biophysica Acta 2012 1822 1387 1396 2-s2.0-84857668006 10.1016/j.bbadis.2012.02.009
51. Vamecq J., Cherkaoui-Malki M., Andreoletti P., Latruffe N., The human peroxisome in health and disease: the story of an oddity becoming a vital organelle. Biochimie 2013 98C 4 15 10.1016/j.biochi.2013.09.019
52. Mannaerts G. P., Van Veldhoven P. P., Metabolic pathways in mammalian peroxisomes. Biochimie 1993 75 3-4 147 158 2-s2.0-0027176127 (Pubitemid 23140164)
53. Poirier Y., Antonenkov V. D., Glumoff T., Hiltunen J. K., Peroxisomal β -oxidation-A metabolic pathway with multiple functions. Biochimica et Biophysica Acta 2006 1763 12 1413 1426 2-s2.0-33845326985 10.1016/j.bbamcr.2006. 08.034 (Pubitemid 44883386)
54. Del Río L. A., Peroxisomes as a cellular source of reactive nitrogen species signal molecules. Archives of Biochemistry and Biophysics 2011 506 1 1 11 2-s2.0-78751630784 10.1016/j.abb.2010.10.022
55. Poll-The B. T., Roels F., Ogier H., Scotto J., Vamecq J., Schutgens R. B. H., Wanders R. J. A., Van Roermund C. W. T., Van Wijland M. J. A., Schram A. W., Tager J. M., Saudubray J.-M., A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). American Journal of Human Genetics 1988 42 3 422 434 2-s2.0-0023878166
56. Jia Z., Pei Z., Li Y., Wei L., Smith K. D., Watkins P. A., X-linked adrenoleukodystrophy: role of very long-chain acyl-CoA synthetases. Molecular Genetics and Metabolism 2004 83 1-2 117 127 2-s2.0-4744359221 10.1016/j.ymgme.2004.06.015 (Pubitemid 39311286)
57. Klaunig J. E., Babich M. A., Baetcke K. P., Cook J. C., Corton J. C., David R. M., DeLuca J. G., Lai D. Y., McKee R. H., Peters J. M., Roberts R. A., Fenner-Crisp P. A., PPAR α agonist-induced rodent tumors: modes of action and human relevance. Critical Reviews in Toxicology 2003 33 6 655 780 2-s2.0-0346156024 (Pubitemid 38037444)
58. Reddy J. K., Goel S. K., Nemali M. R., Transcriptional regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators. Proceedings of the National Academy of Sciences of the United States of America 1986 83 6 1747 1751 2-s2.0-0022446395 (Pubitemid 16018640)
59. Corton J. C., Anderson S. P., Stauber A., Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annual Review of Pharmacology and Toxicology 2000 40 491 518 2-s2.0-0034034671 10.1146/annurev.pharmtox.40.1.491 (Pubitemid 30340691)
60. Wang B., Van Veldhoven P. P., Brees C., Rubio N., Nordgren M., Apanasets O., Kunze M., Baes M., Agostinis P., Fransen M., Mitochondria are targets for peroxisome-derived oxidative stress in cultured mammalian cells. Free Radical Biology and Medicine 2013 65 882 894 10.1016/j.freeradbiomed.2013.08.173
61. Wanders R. J. A., Peroxisomes, lipid metabolism, and peroxisomal disorders. Molecular Genetics and Metabolism 2004 83 1-2 16 27 2-s2.0-4744371532 10.1016/j.ymgme.2004.08.016 (Pubitemid 39311277)
62. Ivashchenko O., Van Veldhoven P. P., Brees C., Ho Y.-S., Terlecky S. R., Fransen M., Intraperoxisomal redox balance in mammalian cells: oxidative stress and interorganellar cross-talk. Molecular Biology of the Cell 2011 22 9 1440 1451 2-s2.0-79955506970 10.1091/mbc.E10-11-0919
63. Walton P. A., Pizzitelli M., Effects of peroxisomal catalase inhibition non mitochondrial function. Frontiers in Physiology 2012 3 108
64. Mimaki M., Wang X., McKenzie M., Thorburn D. R., Ryan M. T., Understanding mitochondrial complex I assembly in health and disease. Biochimica et Biophysica Acta 2012 11 851 862 2-s2.0-80053363463 10.1016/j.bbabio.2011.08. 010
65. Vogel R. O., Dieteren C. E. J., Van Den Heuvel L. P. W. J., Willems P. H. G. M., Smeitink J. A. M., Koopman W. J. H., Nijtmans L. G. J., Identification of mitochondrial complex I assembly intermediates by tracing tagged NDUFS3 demonstrates the entry point of mitochondrial subunits. Journal of Biological Chemistry 2007 282 10 7582 7590 2-s2.0-34147109143 10.1074/jbc.M609410200 (Pubitemid 47093656)
66. Morató L., Galino J., Ruiz M., Calingasan N. Y., Starkov A. A., Dumont M., Naudí A., Martínez J. J., Aubourg P., Portero-Otín M., Pamplona R., Galea E., Beal M. F., Ferrer I., Fourcade S., Pujol A., Pioglitazone halts axonal degeneration in a mouse model of X-linked adrenoleukodystrophy. Brain 2013 136 2432 2443 10.1093/brain/awt143
67. Khan M. M., Ahmad A., Ishrat T., Khan M. B., Hoda M. N., Khuwaja G., Raza S. S., Khan A., Javed H., Vaibhav K., Islam F., Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Research 2010 1328 139 151 2-s2.0-77950594327 10.1016/j.brainres.2010.02.031
68. Cova E., Bongioanni P., Cereda C., Metelli M. R., Salvaneschi L., Bernuzzi S., Guareschi S., Rossi B., Ceroni M., Time course of oxidant markers and antioxidant defenses in subgroups of amyotrophic lateral sclerosis patients. Neurochemistry International 2010 56 5 687 693 2-s2.0-77949569546 10.1016/j.neuint.2010.02.004
69. Elekes O., Venema K., Postema F., Dringen R., Hamprecht B., Korf J., Evidence that stress activates glial lactate formation in vivo assessed with rat hippocampus lactography. Neuroscience Letters 1996 208 1 69 72 2-s2.0-0029871779 10.1016/0304-3940(96)12553-2 (Pubitemid 26128110)
70. Lotharius J., Falsig J., Van Beek J., Payne S., Dringen R., Brundin P., Leist M., Progressive degeneration of human mesencephalic neuron-derived cells triggered by dopamine-dependent oxidative stress is dependent on the mixed-lineage kinase pathway. Journal of Neuroscience 2005 25 27 6329 6342 2-s2.0-21844442345 10.1523/JNEUROSCI.1746-05.2005 (Pubitemid 40962528)
71. Resende R., Moreira P. I., Proença T., Deshpande A., Busciglio J., Pereira C., Oliveira C. R., Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. Free Radical Biology and Medicine 2008 44 12 2051 2057 2-s2.0-43849096294 10.1016/j.freeradbiomed.2008.03.012
72. Choi J.-H., Kim D.-H., Yun I.-J., Chang J.-H., Chun B.-G., Choi S.-H., Zaprinast inhibits hydrogen peroxide-induced lysosomal destabilization and cell death in astrocytes. European Journal of Pharmacology 2007 571 2-3 106 115 2-s2.0-34548598647 10.1016/j.ejphar.2007.06.042 (Pubitemid 47385903)
73. Takuma K., Baba A., Matsuda T., Astrocyte apoptosis: implications for neuroprotection. Progress in Neurobiology 2004 72 2 111 127 2-s2.0-1942520401 10.1016/j.pneurobio.2004.02.001 (Pubitemid 38519589)
74. Giffard R. G., Swanson R. A., Ischemia-induced programmed cell death in astrocytes. Glia 2005 50 4 299 306 2-s2.0-20344403989 10.1002/glia.20167 (Pubitemid 40780836)
75. Di Cesare Mannelli L., Zanardelli M., Failli P., Ghelardini C., Oxaliplatin-induced oxidative stress in nervous system-derived cellular models: could it correlate with in vivo neuropathy? Free Radical Biology and Medicine 2013 61 143 150
76. Hamdi Y., Masmoudi-Kouki O., Kaddour H., Belhadj F., Gandolfo P., Vaudry D., Mokni M., Leprince J., Hachem R., Vaudry H., Tonon M.-C., Amri M., Protective effect of the octadecaneuropeptide on hydrogen peroxide-induced oxidative stress and cell death in cultured rat astrocytes. Journal of Neurochemistry 2011 118 3 416 428 2-s2.0-79960311654 10.1111/j.1471-4159.2011. 07315.x
77. Kassmann C. M., Lappe-Siefke C., Baes M., Brügger B., Mildner A., Werner H. B., Natt O., Michaelis T., Prinz M., Frahm J., Nave K.-A., Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes. Nature Genetics 2007 39 8 969 976 2-s2.0-34547527078 10.1038/ng2070 (Pubitemid 47185174)
78. Ferdinandusse S., Zomer A. W. M., Komen J. C., Van Den Brink C. E., Thanos M., Hamers F. P. T., Wanders R. J. A., Van Der Saag P. T., Poll-The B. T., Brites P., Ataxia with loss of Purkinje cells in a mouse model for Refsum disease. Proceedings of the National Academy of Sciences of the United States of America 2008 105 46 17712 17717 2-s2.0-56649124783 10.1073/pnas.0806066105
79. Pujol A., Hindelang C., Callizot N., Bartsch U., Schachner M., Mandel J. L., Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy. Human Molecular Genetics 2002 11 5 499 505 2-s2.0-0036501313 (Pubitemid 34257486)
80. Baes M., Gressens P., Baumgart E., Carmeliet P., Casteels M., Fransen M., Evrard P., Fahimi D., Declercq P. E., Collen D., Van Veldhoven P. P., Mannaerts G. P., A mouse model for Zellweger syndrome. Nature Genetics 1997 17 1 49 57 2-s2.0-16944361876 10.1038/ng0997-49 (Pubitemid 27377531)
81. Hulshagen L., Krysko O., Bottelbergs A., Huyghe S., Klein R., Van Veldhoven P. P., De Deyn P. P., D'Hooge R., Hartmann D., Baes M., Absence of functional peroxisomes from mouse CNS causes dysmyelination and axon degeneration. Journal of Neuroscience 2008 28 15 4015 4027 2-s2.0-43049167457 10.1523/JNEUROSCI.4968-07.2008